Abiopharma

New Form 424B2 - BARCLAYS BANK PLC <b>Filed:</b> 2026-04-22 <b>AccNo:</b> 0001918704-26-010482 <b>Size:</b> 494 KB

(99% Neutral) PROSPERITY BANCSHARES INC (PB) Announces Business Combination

American Oncology Network to Participate in 11 Sessions at 2026 Community Oncology Alliance Annual Conference

IMAAVY® (nipocalimab-aahu) shows over two years of sustained disease control in a broad population with generalized myasthenia gravis (gMG)

SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF FIRST QUARTER FISCAL YEAR 2026 FINANCIAL RESULTS ON MAY 6, 2026

New Form DEFA14A - Consolidated Water Co. Ltd. <b>Filed:</b> 2026-04-22 <b>AccNo:</b> 0001104659-26-046533 <b>Size:</b> 852 KB

RedHill Biopharma - RedHills Opaganib Enhances Efficacy of Neuroblastoma Chemo Combination and Augment Anti-Tumor Immunity in Triple-Negative Breast Cancer in Preclinical Studies - New Data Presented at AACR 2026

REDHILL BIOPHARMA LTD. (RDHL) Files Form 6-K

OPKO Health’s ModeX Therapeutics Begins Clinical Trial of Tetraspecific Antibody for Treatment of B-cell Lymphomas

(30% Negative) INCANNEX HEALTHCARE INC. (IXHL) Announces Delay in Treatments Trials for Serious Mental Illness Due to Pandemic-Related Challenges, Regulatory Process, Safety Review

Corbus Pharmaceuticals Announces Abstracts Accepted for Presentation at ASCO 2026 Featuring Updated Clinical Data for CRB-701

New Form DEF 14A - Consolidated Water Co. Ltd. <b>Filed:</b> 2026-04-22 <b>AccNo:</b> 0001104659-26-046528 <b>Size:</b> 4 MB

McKesson Corporation - McKesson Corporation Declares Quarterly Dividend

(99% Neutral) SPECTRAL AI, INC. (MDAI) Announces Regulatory Update

(30% Negative) ORRSTOWN FINANCIAL SERVICES INC (ORRF) Reports Q2 2026 Financial Results